Cogent Biosciences

Cogent Biosciences is developing treatments for genetic diseases. Genetic mutations underpin and drive many diseases and require rational precision therapies to cure. Cogent is using established and emerging science to guide drug discovery and pioneer best-in-class therapeutics. Cogent’s most advanced program is Bezuclastinib, a potent and selective inhibitor of the protein Kit, a receptor tyrosine kinase. Kit is commonly mutated in gastrointestinal stromal tumors (GIST), and GIST patients often relapse with current therapeutics. Cogent hopes Bezuclastinib will offer a better clinical profile as it has already shown promising early clinical activity and safety. Cogent also has FGFR inhibitors in preclinical development for oncology.

Jobs:

Associate Director/Director, Patient Recruitment & Site Enga...

Cambridge, MA|12 days ago

Apply

CO-OP: Clinical Operations

Cambridge, MA|14 days ago

Apply

Principal Scientist/Research Investigator, ADME

Cambridge, MA|19 days ago

Apply

Medical Director / Senior Medical Director

Cambridge, MA|34 days ago

Apply

R&D Intern: Cell Biology

Cambridge, MA|41 days ago

Apply

R&D CO-OP: Cell Biology

Cambridge, MA|41 days ago

Apply

CO-OP: Pharmacology (MS or PhD Level)

Cambridge, MA|41 days ago

Apply

Senior Clinical Research Associate

Cambridge, MA|43 days ago

Apply

Associate Scientist, Computational Biology

Cambridge, MA|71 days ago

Apply

Team Lead, Medicinal Chemistry (copy)

Cambridge, MA|75 days ago

Apply

Desktop Support Specialist

Cambridge, MA|100+ days ago

Apply